Clinical Trial

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

Study acronym: PHR
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-01-21; most recent amendment 2026-04-27.
Status change: Recruiting → Active, Not Recruiting 2026-04-27
Status change: Withheld → Recruiting 2025-02-24
Trial Details
NCT Number NCT06792539
Lead Sponsor JointMedica Inc.
Conditions Osteoarthritis of the Hip, Degenerative Joint Disease of Hip, Dysplasia; Hip
Enrollment 238 participants
Start Date 2025-01-22
Primary Completion 2028-04 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-01